We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$5.37M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.7M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.54M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12M
5
NVDA icon
NVIDIA
NVDA
+$1.88M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.88M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$4.62M
3
OCSL icon
Oaktree Specialty Lending
OCSL
+$825K
4
MGI
MoneyGram International, Inc. New
MGI
+$627K
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$562K

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VBTX
2326
DELISTED
Veritex Holdings
VBTX
$1.22K ﹤0.01%
68
– –
HSIC icon
2327
Henry Schein
HSIC
$9.82B
$1.22K ﹤0.01%
15
+7
+88% +$553
BC icon
2328
Brunswick
BC
$5.28B
$1.21K ﹤0.01%
14
– –
BCPC
2329
Balchem Corp
BCPC
$5.72B
$1.21K ﹤0.01%
9
+4
+80% +$514
AVAL icon
2330
Grupo Aval
AVAL
$6.01B
$1.2K ﹤0.01%
515
-890
-63% -$2.13K
EWTX icon
2331
Edgewise Therapeutics
EWTX
$4.73B
$1.19K ﹤0.01%
154
-369
-71% -$3.11K
PETS icon
2332
PetMed Express
PETS
$42.3M
$1.19K ﹤0.01%
86
-11
-11% -$165
SCHE icon
2333
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$1.18K ﹤0.01%
48
– –
COTY icon
2334
Coty
COTY
$2.48B
$1.17K ﹤0.01%
95
+26
+38% +$307
VCEL icon
2335
Vericel Corp
VCEL
$2.31B
$1.17K ﹤0.01%
31
+20
+182% +$657
ANAB icon
2336
AnaptysBio
ANAB
$1.68B
$1.16K ﹤0.01%
57
-6
-10% -$122
DYN icon
2337
Dyne Therapeutics
DYN
$4.9B
$1.16K ﹤0.01%
103
-117
-53% -$1.38K
IDCC icon
2338
InterDigital
IDCC
$8.89B
$1.16K ﹤0.01%
12
– –
ITRI icon
2339
Itron
ITRI
$4.54B
$1.15K ﹤0.01%
16
– –
EDIT icon
2340
Editas Medicine
EDIT
$442M
$1.15K ﹤0.01%
140
-35
-20% -$305
TOST icon
2341
Toast
TOST
$19.9B
$1.15K ﹤0.01%
51
– –
VMBS icon
2342
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
$1.15K ﹤0.01%
25
– –
SBDS
2343
DELISTED
Solo Brands Inc
SBDS
$1.14K ﹤0.01%
+5
New +$1.24K
NEO icon
2344
NeoGenomics
NEO
$2.13B
$1.14K ﹤0.01%
71
– –
VMD icon
2345
Viemed Healthcare
VMD
$371M
$1.13K ﹤0.01%
116
-8
-6% -$81
LEN.B icon
2346
Lennar Class B
LEN.B
$20.8B
$1.13K ﹤0.01%
11
– –
BNDX icon
2347
Vanguard Total International Bond ETF
BNDX
$82.2B
$1.12K ﹤0.01%
+23
New +$1.12K
HOPE icon
2348
Hope Bancorp
HOPE
$1.79B
$1.11K ﹤0.01%
132
-94
-42% -$821
SIG icon
2349
Signet Jewelers
SIG
$3.76B
$1.11K ﹤0.01%
17
-31
-65% -$2.15K
PFBC icon
2350
Preferred Bank
PFBC
$1.25B
$1.1K ﹤0.01%
20
– –
92 93
94
95 96

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.